Pharmacokinetic Study of ASP1517 − Evaluation of the Effect of Kremezin on the Pharmacokinetics of ASP1517 in Non-elderly Healthy Adult Male Subjects, When Administered Concomitantly or in a Time Separated Manner.
Phase of Trial: Phase I
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Roxadustat (Primary) ; Charcoal
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 01 May 2016 Status changed from recruiting to completed.
- 16 Mar 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 03 Mar 2016 New trial record